News and Press Releases
ModeX Therapeutics Leverages ProBioGen’s Expertise for Accelerated COVID-19 Antibody Development
29 May 2024 -- Berlin, Germany -- ProBioGen, a leading contract development and manufacturing organisation (CDMO), known for its innovative solutions in cell engineering and bioprocessing excellence, announces a pivotal...
Category: BioManufacturing, Biotechnology, Pharmaceutical
Posted: May 29, 2024
Cellular Origins and Cell and Gene Therapy Catapult collaborate to demonstrate universal automation of CGT manufacturing
Partnership to develop and implement Cellular Origins’ robotic platform Constellation for universal automation of CGT manufacturing at CGT Catapult’s Stevenage Manufacturing Innovation Centre, UK 29 May 2024 -- Cambridge, UK,...
Category: BioManufacturing, Biotechnology, Drug Discovery
Posted: May 29, 2024
Rentschler Biopharma appoints Patrick Meyer as global head BD Sales and Alliance Management
28 May 2024 – Laupheim, Germany; Milford, MA, US; and Stevenage, UK – Rentschler Biopharma SE, a leading global contract development and manufacturing organisation (CDMO) for biopharmaceuticals, including advanced therapy...
Category: Biotechnology
Posted: May 29, 2024
Independent research demonstrates the extreme safety of Bormioli Pharma’s bottles manufactured with Loop Industries’ 100% recycled, virgin quality PET
Developed from PET resin supplied by Loop Industries, Inc., the containers have extractables values well below even conventional solutions in virgin PET under the most challenging conditions. 28 May 2024...
Category: Manufacturing and Packing
Posted: May 29, 2024
Secarna Pharmaceuticals and Orbit Discovery enter collaboration to discover and develop peptide-conjugated targeted antisense oligonucleotide therapeutics
Partnership expands spectrum of Secarna’s capabilities for the development of targeted ASOs beyond antibodies and sugar molecules New platform capabilities extend the reach of Secarna’s antisense approaches, potentially offering new...
Category: Biotechnology, Pharmaceutical
Posted: May 28, 2024
Exonate appoints Dr Rafiq Hasan as Non-Executive Director
Appointment brings extensive experience in global pharma leadership and progressing ophthalmology drugs to market and further strengthens Board 28 May 2024 -- Cambridgeshire, UK -- Exonate, a biotechnology company developing...
Category: Biotechnology, Pharmaceutical
Posted: May 28, 2024
ACHEMA 2024: Steriline upgrades its zero-loss philosophy
Flexibility, robotics and waste minimisation for a more sustainable and time-saving production of drugs 7 May 2024 – Frankfurt, Germany – ACHEMA 2024, the World Forum for the Process Industries...
Category: BioManufacturing, Manufacturing and Packing
Posted: May 23, 2024
Eisai Showcases Oncology Portfolio and Pipeline at ASCO 2024
23 May 2024 -- Tokyo, Japan -- Eisai Co announced today the presentation of research across multiple types of cancer from its oncology portfolio and pipeline during the 2024 American...
Category: Clinical Trials, Drug Discovery
Posted: May 23, 2024
Record numbers expected at CPHI & PMEC China 2024 as Asian markets boom
Domestic and international markets in Asia surging as CPHI & PMEC China welcomes 60,000 attendees and 3500 exhibitors 23 May 2024 - Shanghai, China and Amsterdam, The Netherlands - CPHI...
Category: Biotechnology, Drug Discovery, Manufacturing and Packing
Posted: May 23, 2024
Sphere Fluidics appoints Curtis Nicholson as director of Sales, EMEA, to support accelerated growth in key markets
23 May 2024 -- Cambridge, UK -- Sphere Fluidics, a leading provider of innovative microfluidics-based solutions for single-cell analysis and isolation, today announced the appointment of Curtis Nicholson as director...
Category: Biotechnology, Pharmaceutical
Posted: May 23, 2024
The Jonas Webb Building, Babraham Research Campus, Babraham, Cambridge CB22 3AT, United Kingdom
Global oncology trial investigator sites increase by half in five years, finds new Phesi analysis
China flagged as significant contributor to growth, but poor investigator selection is causing trial failures 23 May 2024 -- Massachusetts, US -- Phesi, a leading clinical development analytics company, has...
Category: Biotechnology, Clinical Trials
Posted: May 22, 2024
New CRO Focused on Cannabis-based Drug Trials Launched
22 May 2024 -- Georgia, US -- Cannovation Clinical Research Partners, a pioneering Cannabis-Based clinical research organisation (CRO) for Drug and Product Development, is proudly announcing its official launch, marking...
Category: Biotechnology, Clinical Trials, Pharmaceutical
Posted: May 22, 2024
3300 Hamilton Mill Rd Ste 102 PMB 3024 Buford, GA 30519
Invizius’s Pioneering Dialysis Product H-Guard Completes First In-Human Clinical Study
Study demonstrated safety and tolerability of H-Guard, a second generation complement regulator, designed to address serious immune system-driven complications of dialysis Encouraging biomarker data positions H-Guard for upcoming Acute Kidney...
Category: Biotechnology, Pharmaceutical
Posted: May 22, 2024
Suite 2, Ground Floor Orchard Brae House, 30 Queensferry Road, Edinburgh, United Kingdom, EH4 2HS
Closed Loop Medicine appoints Paul Johnson as Non-Executive Director
Appointment of digital healthcare leader to Board to support the company as it enters next phase of commercial development Co-founder and former CEO of Lemonaid Health, a leading innovator in...
Category: Biotechnology, Pharmaceutical
Posted: May 22, 2024
Babraham Research Campus Cambridge CB22 3AT United Kingdom
Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Immunology Biosciences
Transaction to include felzartamab, a potential first-in-class therapeutic candidate with promise as a pipeline-in-a-product across a range of immune-mediated diseases Felzartamab is an investigational anti-CD38 monoclonal antibody that, through its...
Category: Drug Discovery, Pharmaceutical
Posted: May 22, 2024
